A 13-year-old girl with incurable leukemia has been treated with a new therapy called base editing, which involves modifying T-cells to target and kill cancerous cells. The treatment, which is still experimental, has shown promising results, with the girl's cancer currently undetectable. The therapy is a form of biological engineering that uses base editing to modify the genetic code of T-cells, allowing them to target specific cells. The girl is still being monitored to see if the cancer will return.